These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 19212878)

  • 1. Evaluation of biomarkers for pharmacological activity.
    Alonso A; Molenberghs G; Renard D; Darstein C
    J Biopharm Stat; 2009; 19(2):256-72. PubMed ID: 19212878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2001 Jul; 298(1):156-64. PubMed ID: 11408537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimation.
    Wilhelm JA; Veng-Pedersen P; Zakszewski TB; Osifchin E; Waters SJ
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):540-5. PubMed ID: 8574503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice.
    Yancey-Wrona JE; Raymond TJ; Mercer HK; Sadée W; Bilsky EJ
    Life Sci; 2009 Sep; 85(11-12):413-20. PubMed ID: 19583969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    Eissenberg T; Greenwald MK; Johnson RE; Liebson IA; Bigelow GE; Stitzer ML
    J Pharmacol Exp Ther; 1996 Feb; 276(2):449-59. PubMed ID: 8632309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
    Adams JU; Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of narcotic analgesics in the horse: selective blockade of narcotic-induced locomotor activity.
    Combie J; Shults T; Nugent EC; Dougherty J; Tobin T
    Am J Vet Res; 1981 May; 42(5):716-21. PubMed ID: 6114692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 11. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
    Comer SD; Burke TF; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
    Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
    Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiopulmonary effects of carfentanil in dama gazelles (Gazella dama).
    Schumacher J; Heard DJ; Young L; Citino SB
    J Zoo Wildl Med; 1997 Jun; 28(2):166-70. PubMed ID: 9279405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of opioid compounds on feeding and activity of the cockroach, Periplaneta americana.
    Cooper PD; Dennis SR; Woodman JD; Cowlings A; Donnelly C
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Apr; 151(3):298-302. PubMed ID: 20005975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isobolographic analysis of multimodal analgesia in an animal model of visceral acute pain.
    Miranda HF; Prieto JC; Puig MM; Pinardi G
    Pharmacol Biochem Behav; 2008 Feb; 88(4):481-6. PubMed ID: 18023854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the antagonistic effects of 6 beta-naltrexol and naltrexone against morphine analgesia].
    Yan LD; Gong ZH; Yao XJ; Qin BY
    Yao Xue Xue Bao; 2003 Aug; 38(8):578-81. PubMed ID: 14628446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
    Barrett AC; Smith ES; Picker MJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.